MarketWatch) — German drugmaker Merck KGaA on Thursday agreed to buy Europe’s largest biotechnology company, Serono, for $13.3 billion, just five months after the Swiss company took down the for-sale sign.
*For more on this story,
read the full MarketWatch
article.
